3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Other hematologic neoplasm
16
Lymphoid
16
Gastrointestinal
15
Thoracic
7
Plasma cell
4
Myeloid
4
Genitourinary
4
Breast
3
Other
2
Classical hematology
2
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Anemia, Refractory, with Excess of Blasts
168
Myelodysplastic Syndromes
160
Leukemia
156
Anemia
151
Leukemia, Myeloid, Acute
144
Neoplasms
124
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Leukemia, Myelomonocytic, Chronic
111
Multiple Myeloma
90
Myeloproliferative Disorders
89
Leukemia, Lymphocytic, Chronic, B-Cell
87
Lymphoma, Non-Hodgkin
76
Hodgkin Disease
71
Lymphoma
66
Congenital Abnormalities
64
Anemia, Refractory
64
Venous Thromboembolism
63
Thrombocytopenia
59
Blast Crisis
57
Leukemia, Myeloid, Chronic-Phase
56
Leukemia, Myeloid, Accelerated Phase
52
Lymphoma, Follicular
51
Myelodysplastic-Myeloproliferative Diseases
48
Anemia, Aplastic
46
Primary Myelofibrosis
44
Lymphoma, Mantle-Cell
44
Neoplasms, Plasma Cell
43
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
41
Burkitt Lymphoma
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
COVID-19
×
Classical hematology
×
Clear all
NCT05226416
2023-05-09
ACTIV4
Eurasian Association of Therapists
Completed
3,554 enrolled
NCT04670094
2022-11-09
Comorbidities
University of Milano Bicocca
Completed
4,555 enrolled